SOLIFENACIN

SynDRA canonical compound SYN0019706 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CHRM3
Mechanism of action	Acetylcholine receptor antagonist
Indication	urinary incontinence, urinary frequency
Disease area	urology

All known targets

YM-67905
YM-905
solifenacin succinate
vesicare
Solifenacine
Solifenacina
NSC-759144
Vesicare
Vesikur
Solifenacin succinate
Solifenacin succinate [USAN]
Solifenacin (INN)
Solifenacin [INN:BAN]
Vesicare (TN)
YM-53705
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylatemonosuccinate
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
Butanedioic acid, compd with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
Butanedioic acid, cmpd. with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
1-azabicyclo[2.2.2]oct-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
1-azabicyclo[2.2.2]octan-3-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo(2.2.2)oct-3-yl ester, (1S)-, butanedioate (1:1)
solifenacin-succinate
A8910SQJ1U
NSC 759144
solifenacine
solifenacinum
RefChem:56468
DTXCID8028264
G04BD08
MFCD18910847
SOLIFENACIN [INN]
Soliten
(+)-Solifenacin
YM905 (free base)
NCGC00168778-01
UNII-A8910SQJ1U
s5238